– CNBC
EXCLUSIVE: Alcohol Disorder Focused Adial Pharmaceuticals Secures US Patent
Adial Pharmaceuticals' genetic diagnostic patent, expanding treatment for alcohol and drug dependencies. CEO highlights the significance.
Related Posts
Robinhood Markets Sees FY24 Adjusted Operating Expenses And SBC Of $1.85B-$1.95B
Financial Outlookfor the Year Ending December 31, 2024 Outlook(in millions) Total operating expenses (GAAP)$1,850 - $1,950Significant reconciliation items(1)—Adjusted Operating Expenses and SBC (non-GAAP)$1,850
Craft Cannabis Co. Grown Rogue Expands In This Booming East Cost Weed Market Via New Acquisition
Grown Rogue International Inc. (CSE: GRIN) (OTC: GRUSF) has obtained licensing approval with the New Jersey Cannabis Regulatory Commission and closed its first option to acquire 44% of ABCO Garden State, LLC on Friday, May 31.Obie Strickler, the company's CEO, said "All regulatory approvals from the CRC have been received and we exercised and closed our option to acquire 44% of ABCO."Under the deal, Grown Rogue has an option to acquire 70% of ABCO through two options, including Option 1 and Option 2, for 44% and 26%, respectively.
Hewlett Packard Enterprise, Hologic And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session
U.S. stock futures were lower this morning, with the Dow Jones futures falling around 100 points on Tuesday.
Shares of Hewlett Packard Enterprise Company (NYSE: HPE) shares fell sharply in pre-market trading on Tuesday.